Prognostic Value of Lymph Node Density on Cancer Staging System for Gastric Cancer Without Distal Metastasis: a Population-based Analysis of SEER Database

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2022 Sep 29

PMID 36175896

Authors

Yuhua Liu

Hao Cui

Xinxin Xu

Wenquan Liang

Affiliations

Soon will be listed here.

Abstract

Background: Accurate tumor staging is the cornerstone of tumor treatment. Current tumor staging system for gastric cancer (GC) is based on regional positive lymph nodes while ignoring the total number of examined lymph nodes. We aim to assess the prognostic value of lymph node density (LND), the ratio of positive nodes to the total number examined nodes, in GC without distal metastasis.

Methods: Clinical information of patients with histologically confirmed GC and without distal metastasis was identified from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015. The X-Tile software was used to identify the ideal prognosis-related cutoff point for LND. The prognostic value of LND on cancer-specific survival (CSS) and overall survival (OS) was assessed in Cox regression models. Subgroup analysis stratified by LND was performed on current lymph node staging system to further explore the interaction between LND and current lymph node staging system.

Results: A total of 4281 participants were identified from the SEER database for the final analysis. The optimal prognosis-related cutoff values of LND were calculated as 0.1 and 0.4, and LND was divided into three levels: LND1 (< 0.1), LND2 (> = 0.1, < 0.4), and LND3 (> = 0.4). LND3 was associated with worse CSS and OS in GC patients. Compared to patients with LND1, those with LND2 and LND3 had 2.43 (HR = 2.43, 95% CI 2.09-2.84, P < 0.001) and 4.69 (HR = 4.69, 95% CI 4.02-5.48, P < 0.001) folds increase in mortality in CSS, respectively. Similar results were found in the evaluation of OS in GC patients. Subgroup analysis stratified by LND also found that patients in the same current lymph node stage still had different prognosis due to the different LND levels after adjustment for other prognosis-related covariates (all P values < 0.001).

Conclusion: LND is an independent prognostic factor for GC without distal metastasis. In the current lymph node staging system, LND has potential value in further accurately classifying GC patients without distal metastasis.

Citing Articles

Comparison of the predictive performance of three lymph node staging systems for late-onset gastric cancer patients after surgery.

Chen S, Ding P, Zhao Q Front Surg. 2024; 11:1376702.

PMID: 38919979 PMC: 11196640. DOI: 10.3389/fsurg.2024.1376702.

Combination of clinical and spectral-CT iodine concentration for predicting liver metastasis in gastric cancer: a preliminary study.

She Y, Liu X, Liu H, Yang H, Zhang W, Han Y Abdom Radiol (NY). 2024; 49(10):3438-3449.

PMID: 38744700 DOI: 10.1007/s00261-024-04346-0.

Effect of the number of negative lymph nodes removed on the survival and recurrence rate after gastrectomy in patients with gastric cancer: a multicenter retrospective cohort study.

Bahardoust M, Kheirabadi M, Donyadideh G, Khaleghian M, Haghmoradi M, TizMaghz A BMC Surg. 2023; 23(1):246.

PMID: 37605178 PMC: 10441750. DOI: 10.1186/s12893-023-02154-9.

Evaluation of the prognostic value of negative to positive lymph node ratio in gastric cancer: results from multi-institutional cohorts from western and eastern datasets - Cohort study.

Wang X, Wang P, Wang W, Sun Z, Wang Z, Zhang R Ann Med Surg (Lond). 2023; 85(6):2348-2355.

PMID: 37363559 PMC: 10289599. DOI: 10.1097/MS9.0000000000000775.

Positive lymph node ratio as a prognostic factor for gastric cancer patients: Is it going to supersede positive lymph node number in guidelines?.

Capkinoglu E, Tufan A, Omeroglu S, Tanal M, Guven O, Demir U Medicine (Baltimore). 2023; 102(20):e33757.

PMID: 37335735 PMC: 10194709. DOI: 10.1097/MD.0000000000033757.

References

Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M . Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011; 37(4):305-11. DOI: 10.1016/j.ejso.2011.01.013. View

Zhou Y, Yang L, Wang Z, He M, Yun J, Zhang D . Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy. J Cancer. 2018; 9(4):660-666. PMC: 5858487. DOI: 10.7150/jca.22016. View

Sacerdotianu V, Ungureanu B, Iordache S, Filip M, Pirici D, Liliac I . Accuracy of Endoscopic Ultrasonography for Gastric Cancer Staging. Curr Health Sci J. 2022; 48(1):88-94. PMC: 9289590. DOI: 10.12865/CHSJ.48.01.13. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Dicken B, Bigam D, Cass C, Mackey J, Joy A, Hamilton S . Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2004; 241(1):27-39. PMC: 1356843. DOI: 10.1097/01.sla.0000149300.28588.23. View

Kernan W, Viscoli C, Brass L, Broderick J, Brott T, Feldmann E . Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000; 343(25):1826-32. DOI: 10.1056/NEJM200012213432501. View

Amit M, Tam S, Boonsripitayanon M, Cabanillas M, Busaidy N, Grubbs E . Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2017; 144(2):108-114. PMC: 5839287. DOI: 10.1001/jamaoto.2017.2416. View

Chae S, Lee A, Lee J . The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer. 2011; 14(2):166-71. DOI: 10.1007/s10120-011-0024-6. View

Camp R, Dolled-Filhart M, Rimm D . X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10(21):7252-9. DOI: 10.1158/1078-0432.CCR-04-0713. View

10.

Kim J, Kim C, Lee Y, Lee J, Chae Y . Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers. Pathology. 2017; 49(6):589-595. DOI: 10.1016/j.pathol.2017.06.003. View

11.

Chang W, Lin C, Yang C, Lin C, Chen Y . Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma. Clin Oral Investig. 2017; 22(3):1513-1521. PMC: 5866838. DOI: 10.1007/s00784-017-2247-3. View

12.

Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A . Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012; 3(3):251-61. PMC: 3418539. DOI: 10.3978/j.issn.2078-6891.2012.021. View

13.

Wang X, Appleby D, Zhang X, Gan L, Wang J, Wan F . Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancer. Br J Surg. 2013; 100(4):505-14. DOI: 10.1002/bjs.9014. View

14.

Kutlu O, Watchell M, Dissanaike S . Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol. 2015; 24(2):84-8. DOI: 10.1016/j.suronc.2015.03.001. View

15.

Meng N, Wang Y, Wang H, Zhou J, Wang S . Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation. Front Med (Lausanne). 2022; 9:829702. PMC: 8931263. DOI: 10.3389/fmed.2022.829702. View

16.

Ye L, Rao J, Fan X, Ji Q, Hu C, Ying H . Impact of tumor dimensions and lymph node density on the survival of patients with hypopharyngeal squamous cell carcinoma. Cancer Manag Res. 2018; 10:4679-4688. PMC: 6201846. DOI: 10.2147/CMAR.S178750. View

17.

Cayonu M, Unsal Tuna E, Acar A, Kayali Dinc A, Sahin M, Boynuegri S . Lymph node yield and lymph node density for elective level II-IV neck dissections in laryngeal squamous cell carcinoma patients. Eur Arch Otorhinolaryngol. 2019; 276(10):2923-2927. DOI: 10.1007/s00405-019-05560-z. View

18.

Jiao X, Deng J, Zhang R, Wu L, Wang L, Liu H . Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol. 2014; 20(13):3640-8. PMC: 3974533. DOI: 10.3748/wjg.v20.i13.3640. View

19.

Lee Y, Yang P, Zhong Y, Clancy T, Lin M, Wang J . Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry. Am J Clin Oncol. 2014; 40(1):35-41. DOI: 10.1097/COC.0000000000000110. View

20.

Liu J, Su M, Wang J, Zhang G, Zhou J, Zhang A . A novel grade-lymph node ratio model predicts the prognosis of the advanced gastric cancer patients after neoadjuvant radiotherapy. Oncotarget. 2016; 8(8):14058-14067. PMC: 5355162. DOI: 10.18632/oncotarget.12573. View